Condition (MeSH)
Mesenteric Ischemia
ClinicalTrials.gov lists 23 trials for Mesenteric Ischemia or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
23 of the 23 trials are tagged with Mesenteric Ischemia itself; the rest are tagged with a narrower condition beneath it.
When did Mesenteric Ischemia trials start? (13)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 4
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2025 | 3 |
| 2024 | 2 |
| 2023 | 3 |
| 2021 | 1 |
| 2020 | 1 |
| 2018 | 3 |
| 2017 | 1 |
| 2016 | 1 |
| 2015 | 4 |
Showing 10 of 13 earlier years.
No forecast is made for this condition: it averages 1.8 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 2 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Mesenteric Ischemia trials in? (4)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 3 | 2 |
| Phase 4 | 2 |
| Not applicable | 6 |
| Observational | 13 |
How many Mesenteric Ischemia trials are recruiting? (6)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 1 |
| Recruiting | 5 |
| Active, not recruiting | 1 |
| Completed | 8 |
| Suspended | 1 |
Showing 5 of 6 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which drugs are being tested for Mesenteric Ischemia? (2)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| (LMW)heparin | 2 |
| Rivaroxaban | 1 |
Interventions as named in the registry (6)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| BLOOD SAMPLES | 1 |
| Warfarin VKA | 1 |
| Fragmin P Forte (dalteparin sodium) | 1 |
| SmofKabiven | 1 |
| Apixaban IR | 1 |
Showing 5 of 6 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Mesenteric Ischemia trials report? (10)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Neoplasms benign, malignant and unspecified (incl cysts and polyps) - Other, specify | 56 | 1 |
| Bleeding | 9 | 1 |
| Lung infection | 8 | 1 |
| Anemia | 6 | 1 |
| Sepsis | 6 | 1 |
Showing 5 of 10 adverse events.
Which publications cover Mesenteric Ischemia? (57)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
Showing 5 of 57 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: lead sponsors, prevalence, rare-disease identity, and sub-conditions in mesh.